Literature DB >> 19930870

Ankle-brachial index screening for peripheral artery disease in asymptomatic patients between 50 and 70 years of age.

Andrej Kravos1, K Bubnic-Sotosek.   

Abstract

Asymptomatic peripheral arterial disease (PAD) can be easily identified using the ankle-brachial index (ABI). This study was designed to investigate the benefits of performing ABI in patients aged 50 - 70 years. A random sample of 107 patients was chosen and data on gender, age, risk factors and laboratory tests were collected and the ABI measured. Twenty (19%) patients were found to have PAD. Smoking, high total cholesterol, high triglycerides and diabetes mellitus were shown to be associated with a low ABI and the presence of PAD. Age, diabetes and smoking were identified as the strongest predictors of PAD. Having more risk factors for PAD also predicted a lower ABI. These results suggest that measuring ABI is not necessary in patients aged 50 - 70 years if they only have one risk factor, with the exception of patients with diabetes and those who smoke. In contrast, measuring ABI seems to be useful for patients with multiple risk factors for PAD, although additional studies are required.

Entities:  

Mesh:

Year:  2009        PMID: 19930870     DOI: 10.1177/147323000903700540

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  3 in total

1.  A study of prognostic factors in Chinese patients with diabetic foot ulcers.

Authors:  Aiping Wang; Xinjuan Sun; Wei Wang; Kechun Jiang
Journal:  Diabet Foot Ankle       Date:  2014-03-11

2.  Presence of asymptomatic Peripheral Arterial Disease in combination with common risk factors elevates the cardiovascular risk Substantially.

Authors:  Fredrik Sartipy; Antonio José Garcia Pereira Filho; Fredrik Lundin; Eric Wahlberg; Birgitta Sigvant
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-04-18

3.  miR‑124‑3p regulates angiogenesis in peripheral arterial disease by targeting STAT3.

Authors:  Yefei Shi; Xu Xu; Peipei Luan; Wenxin Kou; Mingjie Li; Qing Yu; Jianhui Zhuang; Yawei Xu; Wenhui Peng; Weixia Jian
Journal:  Mol Med Rep       Date:  2020-09-25       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.